Literature DB >> 9090681

Apoptosis in development and disease of the nervous system: II. Apoptosis in childhood neurologic disease.

H A Gelbard1, R M Boustany, N F Schor.   

Abstract

The loss of cells in the human nervous system has long been known as the hallmark of incurable degenerative disease. Recent studies that began with attempts to understand cell loss during normal development have now begun to contribute to our understanding of the process of pathological cell loss. In many neurodegenerative conditions, it has become clear that apoptosis, or programmed cell death, plays a role in the diminution of cell number. In the cases of human immunodeficiency virus-associated encephalopathy and several of the hereditary neurodegenerative disorders, triggers and mediators of this process have been identified. This identification is not only the first step toward treatment of such disorders, but it also raises the possibility of exploiting this information to design targeted apoptosis-based therapies for tumors of the nervous system.

Entities:  

Mesh:

Year:  1997        PMID: 9090681     DOI: 10.1016/s0887-8994(96)00258-5

Source DB:  PubMed          Journal:  Pediatr Neurol        ISSN: 0887-8994            Impact factor:   3.372


  3 in total

Review 1.  Neuroblastoma as a neurobiological disease.

Authors:  N F Schor
Journal:  J Neurooncol       Date:  1999-01       Impact factor: 4.130

2.  Neuronal apoptosis following human brain injury.

Authors:  R Hausmann; T Biermann; I Wiest; J Tübel; P Betz
Journal:  Int J Legal Med       Date:  2003-11-18       Impact factor: 2.686

3.  Exogenous Flupirtine as Potential Treatment for CLN3 Disease.

Authors:  Katia Maalouf; Joelle Makoukji; Sara Saab; Nadine J Makhoul; Angelica V Carmona; Nihar Kinarivala; Noël Ghanem; Paul C Trippier; Rose-Mary Boustany
Journal:  Cells       Date:  2020-08-11       Impact factor: 6.600

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.